Silicon Valley’s psychedelic wonder drug is almost here
A new startup is hoping to cure depression, opioid addiction and alcoholism. Ruth Reader investigates how MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment while cutting out the downsides of tripping. But, with only anecdotal evidence of its effectiveness, will it even work?
From Fast Company